Wendy Lynn Barnes

See Remarks at GoodRx Holdings Inc.

Sits on 1 board. Last updated September 28, 2026

Time on boards

Boards served
1
Current seats
1
Board service
2 years
Director since
2025

2 years of board service in total across 1 board, counting each seat separately. Longest: GoodRx Holdings Inc., 1 year.

GoodRx Holdings Inc. Director · See Remarks
1 year · Since 2025

Shareholder support

Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Jul 15, 2026 GoodRx Holdings Inc. Option exercise +115,148 — —
Jul 15, 2026 GoodRx Holdings Inc. Shares withheld for tax −50,021 $3.01 $150,563
Jul 15, 2026 GoodRx Holdings Inc. Option exercise +51,177 — —
Jul 15, 2026 GoodRx Holdings Inc. Shares withheld for tax −22,232 $3.01 $66,918
Jul 15, 2026 GoodRx Holdings Inc. Option exercise +110,963 — —
Jul 15, 2026 GoodRx Holdings Inc. Shares withheld for tax −48,203 $3.01 $145,091
Apr 15, 2026 GoodRx Holdings Inc. Option exercise +115,148 — —
Apr 15, 2026 GoodRx Holdings Inc. Shares withheld for tax −50,021 $2.23 $111,547
Apr 15, 2026 GoodRx Holdings Inc. Option exercise +51,177 — —
Apr 15, 2026 GoodRx Holdings Inc. Shares withheld for tax −22,232 $2.23 $49,577
Apr 15, 2026 GoodRx Holdings Inc. Option exercise +110,963 — —
Apr 15, 2026 GoodRx Holdings Inc. Shares withheld for tax −48,203 $2.23 $107,493
Jan 15, 2026 GoodRx Holdings Inc. Option exercise +460,594 — —
Jan 15, 2026 GoodRx Holdings Inc. Shares withheld for tax −148,383 $2.75 $408,053
Jan 15, 2026 GoodRx Holdings Inc. Option exercise +204,708 — —

Questions about Wendy Lynn Barnes

What boards is Wendy Lynn Barnes on?

Wendy Lynn Barnes sits on the board of GoodRx Holdings Inc.

How long has Wendy Lynn Barnes served on boards?

Our records show at least 2 years of board service across 1 board, the earliest from 2025.

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.